Elanco Animal Health, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-224.00
488.00
-1,195.00
-72.00
-567.00
-672.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
99.00
149.00
-300.00
-462.00
-87.00
165.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
560.00
541.00
271.00
452.00
483.00
-41.00
Cash Flow from Investing Activities
-279.00
1,158.00
-169.00
-179.00
-530.00
-4,779.00
Cash Flow from Financing Activities
-275.00
-1,492.00
-83.00
-549.00
210.00
4,953.00
Net Cash Inflow / Outflow
77.00
116.00
7.00
-293.00
132.00
160.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
71.00
-91.00
-12.00
-17.00
-31.00
26.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Elanco Animal Health, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-224
98.463
-322.00
-327.50%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
99
11.539
88.00
757.96%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
560
287.556
273.00
94.74%
Cash Flow from Investing Activities
-279
-35.183
-244.00
-693.00%
Cash Flow from Financing Activities
-275
-253.905
-22.00
-8.31%
Net Cash Inflow / Outflow
77
10.395
67.00
640.74%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
71
11.927
60.00
495.29%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 3.51% vs 99.63% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
560.00
541.00
3.51%






